Skip to main content
Figure 4 | Journal of Ovarian Research

Figure 4

From: Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft

Figure 4

HUVECs proliferation and migration assay. (A) By the MTS assay, HUVECs number was measured by the MTS assay upon different treatment for 72 h. (B) The HUVECs migration was measured by Transwell assay in the co-cultured system (×400). (C) Data was shown as the mean of the number of migration HUVECs in five representative fields. *, P < 0.01 compared with control. **, P < 0.01 compared with chA21 or trastuzumab alone.

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us